iRhythm executive sells shares to cover RSU taxes
iRhythm Holdings, Inc. executive reports share sale tied to tax obligations.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
iRhythm Holdings, Inc. executive reports share sale tied to tax obligations. Chief Medical and Scientific Officer Minang Turakhia reported the sale of 1,423 shares of common stock on July 2, 2026 at an average price of $124.71 per share. A footnote explains these shares were sold to cover tax withholding and remittance obligations related to the vesting of Restricted Stock Units. After this transaction, Turakhia directly holds 53,620 shares of iRhythm common stock.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 1,423 | $124.71 | $177K |
Footnotes (1)
- F1. These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs).
Key Figures
Key Terms
Restricted Stock Units (RSUs) financial
tax withholding financial
open-market sale financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did iRhythm Holdings (IRTC) report for Minang Turakhia?
Does the Form 4 indicate any derivative or option exercises for iRhythm (IRTC)?
AI-generated analysis. How Rhea-AI works. Not financial advice.